Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue

Explore a 20-minute webinar presented by Dr. Chi-Cheng Huang, a qualified specialist in various surgical fields, on the concordance of targeted sequencing results between circulating tumor DNA (ctDNA) and paired tumor samples from early breast cancers. Delve into the study evaluating whether pre-operative ctDNA testing could serve as a non-invasive surrogate for variants typically revealed after definitive surgery. Examine the implications of high or poor concordance on the clinical adoption of liquid biopsy in early breast cancer. Learn about the VGH-TAYLOR study, a comprehensive precision medicine research project on the heterogeneity of Taiwanese breast cancer patients. Gain insights into the potential of ctDNA testing in improving breast cancer diagnosis and treatment strategies. Earn PACE credits by watching the webinar and following the provided instructions.

Concordance of targeted sequencing from circulating tumor DNA and paired tumor tissue